| 2000 |
Crystal structure of the eEF1A–eEF1Bα complex determined at 1.67 Å resolution revealed that eEF1Bα inserts one end between the switch 1 and 2 regions of eEF1A to destroy the Mg²⁺ binding site, and the other end contacts domain 2 of eEF1A in the region that binds the CCA-aminoacyl end of tRNA, suggesting competition between eEF1Bα and aa-tRNA as a central element in channeling translation substrates. |
X-ray crystallography (1.67 Å), structural analysis |
Molecular cell |
High |
11106763
|
| 2001 |
Crystal structures of eEF1A–eEF1Bα–GDP–Mg²⁺, –GDP, and –GDPNP intermediates defined the nucleotide exchange mechanism; a lethal K205A mutation in eEF1Bα that inserts into the Mg²⁺ binding site of eEF1A confirmed the essential role of Mg²⁺ displacement in nucleotide exchange. |
X-ray crystallography (2.05–3.0 Å), site-directed mutagenesis, in vivo viability assay |
Nature structural biology |
High |
11373622
|
| 1998 |
Site-directed mutagenesis of yeast eEF1A at the nucleotide specificity sequence NKMD (residues 153–156) produced viable mutants with increased Km for GTP and reduced GTP hydrolysis rates; N153D was lethal, establishing that this sequence is critical for GTPase function and translational fidelity. |
Site-directed mutagenesis, in vitro poly(U)-directed translation assay, GTP hydrolysis assay |
The Journal of biological chemistry |
High |
9786872
|
| 2002 |
Exportin 5 (Exp5/RanBP21) mediates nuclear export of eEF1A indirectly via aminoacylated tRNAs; eEF1A binds Exp5 only through aa-tRNA, not directly. Fractionation showed that eEF1A and all other elongation factors are strictly excluded from nuclei, arguing that nuclear translation is actively suppressed. |
Nuclear fractionation, transport reconstitution assays, subcellular localization |
The EMBO journal |
High |
12426392
|
| 2003 |
TCTP (translationally controlled tumor protein) acts as a guanine nucleotide dissociation inhibitor (GDI) for eEF1A: it preferentially stabilizes the GDP-bound form of eEF1A and impairs the GDP→GTP exchange promoted by eEF1Bβ, as shown by in vitro and in vivo binding assays. |
Yeast two-hybrid, co-immunoprecipitation, MS, in vitro nucleotide exchange assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
14623968
|
| 2004 |
eEF1A·GTP binding to the valylated 3′ tRNA-like structure of TYMV genomic RNA strongly represses minus-strand RNA synthesis by the viral RdRp in vitro; repression was aa-tRNA-dependent and required eEF1A·GTP but not the GDP form, suggesting a regulatory switch between translation and replication roles. |
In vitro RdRp transcription assay, eEF1A·GTP binding competition |
Virology |
High |
15033564
|
| 2007 |
eEF1A binds the 3′ stem-loop of West Nile virus genomic RNA and colocalizes with viral replication complexes; mutations that decreased in vitro eEF1A binding to the 3′ SL reduced viral minus-strand RNA synthesis without affecting polyprotein translation, establishing that eEF1A facilitates flavivirus minus-strand synthesis. |
RNase footprinting, nitrocellulose filter binding, infectious clone mutagenesis, minus-strand RNA quantification, co-immunoprecipitation, immunofluorescence colocalization |
Journal of virology |
High |
17626087
|
| 2008 |
eEF1A plays a central role in nuclear export of proteins in mammalian cells via a transcription-dependent nuclear export motif (TD-NEM); eEF1A interacts specifically with TD-NEM of VHL and PABP1, and siRNA knockdown or antibody depletion of eEF1A prevents nuclear export of TD-NEM-containing proteins. eEF1A acts from the cytoplasmic face of the nuclear envelope without itself entering the nucleus. |
siRNA knockdown, antibody-mediated depletion, in vivo and in vitro nuclear export assay, point mutagenesis of TD-NEM, actinomycin D treatment |
Molecular biology of the cell |
High |
18799616
|
| 2008 |
The SAM domain of RhoGAP DLC1 binds eEF1A1 (EF1A1); structural and mutagenesis analysis identified F38/L39 in the DLC1 SAM hydrophobic patch as an indispensable interaction motif. DLC1 SAM facilitates redistribution of eEF1A1 to the membrane periphery upon growth factor stimulation, and this interaction is required for full DLC1-mediated suppression of cell migration. |
Protein precipitation/MS, NMR solution structure of DLC1-SAM, site-directed mutagenesis, co-immunoprecipitation, cell migration assay |
Journal of cell science |
High |
19158340
|
| 2008 |
BPOZ-2 directly binds eEF1A1 through its ankyrin repeats and both BTB/POZ domains (interacting with domains I and III of eEF1A1), promotes eEF1A1 ubiquitylation and degradation, inhibits GTP binding to eEF1A1, and suppresses translation in an in vitro reticulocyte assay. |
Yeast two-hybrid, pull-down, co-immunoprecipitation, in vitro ubiquitylation assay, GTP-binding assay, in vitro translation assay |
Genes to cells |
Medium |
18459963
|
| 2009 |
The Legionella pneumophila Dot/Icm effector SidI specifically interacts with eEF1A and eEF1Bγ, inhibiting host protein synthesis; SidI mutants retaining target-binding but lacking toxicity were isolated, and L. pneumophila infection induces eEF1A-mediated HSF1 activation in a virulence-dependent manner. |
Yeast toxicity assay, co-immunoprecipitation, protein synthesis inhibition assay, SidI substitution mutagenesis, HSF1 activation measurement |
Cellular microbiology |
Medium |
19386084
|
| 2009 |
EF1A1 binds the 5′-UTR of osteopontin (OPN) mRNA to regulate OPN mRNA stability; this interaction is actin-dependent: EF1A1 bound to F-actin in Hep3B cells is unavailable for mRNA binding, and pharmacologic increase of the G:F actin ratio releases EF1A1 to bind OPN mRNA and increase its half-life. |
mRNA half-life assay, RNA binding assay, actin co-sedimentation, pharmacologic G:F actin manipulation |
Experimental cell research |
Medium |
19026636
|
| 2010 |
TGF-β type I receptor (TβR-I) phosphorylates eEF1A1 at Ser300 in vitro and in vivo; phosphorylation at Ser300 reduces aa-tRNA binding to eEF1A1 and inhibits protein synthesis and cell proliferation. Phosphomimetic Ser300 mutations phenocopy TGF-β-dependent inhibition of translation. |
In vitro kinase assay, site-directed mutagenesis, in vivo phosphorylation analysis, in vitro translation assay, cell proliferation assay |
Current biology |
High |
20832312
|
| 2010 |
eEF1Bα disrupts eEF1A-induced actin organization, and eEF1Bα F163 in the domain shared with actin and aa-tRNA binding governs this activity. Combining the F163A lethal mutation with W130A intragenic suppressor or with the K205A mutation dramatically reduces eEF1Bα–eEF1A affinity and restores viability while increasing actin bundling, establishing that eEF1Bα coordinates the dual roles of eEF1A in actin organization and translation. |
Site-directed mutagenesis, actin bundling assay, nucleotide exchange activity assay, yeast growth phenotype, cell morphology analysis |
The Journal of biological chemistry |
Medium |
19095653
|
| 2010 |
eEF1A·GDP (but not eEF1A·GTP) directly activates sphingosine kinase 1 (SK1) in vitro; enhancing cellular eEF1A·GDP levels via TCTP (a GDI) increases SK1 activity in cells. The truncated oncogenic isoform PTI-1, which lacks the G-protein domain, constitutively activates SK1, and SK1 inhibition blocks PTI-1-induced neoplastic transformation. |
In vitro SK1 activity assay with GTP/GDP-loaded eEF1A, cell-based SK1 activity assay, dominant-negative SK1 and chemical inhibitor rescue |
Oncogene |
Medium |
20838377
|
| 2011 |
eEF1A binds the C-terminal domain (CTD) of Gcn2 kinase independently of ribosomes; this interaction is reduced during amino acid starvation and by uncharged tRNAs in vitro. Purified eEF1A inhibits Gcn2-mediated phosphorylation of eIF2α but not Gcn2 autophosphorylation, identifying eEF1A as a Gcn2 inhibitor that modulates the amino acid starvation response. |
Affinity purification (His-eEF1A), co-immunoprecipitation, GST pulldown with purified proteins, in vitro Gcn2 kinase assay |
The Journal of biological chemistry |
High |
21849502
|
| 2011 |
Cytoplasmic AID in B cells exists in stoichiometric complex with eEF1A; the interaction depends on the C-terminal domain of eEF1A (not the GTP or tRNA binding regions) and on the AID region responsible for cytosolic retention, establishing eEF1A as a cytosolic retention factor for AID. |
Endogenous tagging of AID, co-immunoprecipitation, domain mapping, sucrose gradient sedimentation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
22042842
|
| 2012 |
PUF proteins (FBF) and Argonaute (CSR-1/Ago) form a conserved complex with eEF1A in both C. elegans and mammals; FBF-1–CSR-1 heterodimer inhibits eEF1A GTPase activity in vitro; the mammalian PUM2–Ago–eEF1A complex inhibits translation of reporters after initiation, causing ribosome accumulation within the ORF at the site where the nascent peptide exits the ribosome. |
Co-immunoprecipitation, recombinant protein pulldown, in vitro GTPase assay, in vitro translation with polysome/ribosome profiling |
Nature structural & molecular biology |
High |
22231398
|
| 2012 |
eEF1A associates with defective ribosomal products (DRiPs) at the ribosome to generate a signal that triggers aggresome formation upon proteasome inhibition; the Legionella toxin SidI, which inhibits translation but spares this eEF1A function, demonstrated that the aggresome-signaling role of eEF1A is separable from its translation elongation function. |
siRNA knockdown, aggresome formation assay, SidI toxin pharmacological dissection |
Journal of cell science |
Medium |
22357952
|
| 2013 |
eEF1A binds to Snail transcription factors (via their SNAG domain) when Snail is bound to the E-cadherin promoter, and escorts Snail from the nucleus to the cytoplasm via the Exportin5–aa-tRNA complex; this export is regulated by phosphorylation of Snail, establishing a nuclear role for eEF1A in attenuating transcription factor activity. |
Co-immunoprecipitation, nuclear export assay, chromatin immunoprecipitation, phosphorylation analysis |
Cell reports |
Medium |
24209753
|
| 2014 |
eEF1A1 isoform (but not eEF1A2) participates in the entire heat shock response: upon stress it recruits HSF1 to the HSP70 promoter to activate transcription, then associates with elongating RNA Pol II and the HSP70 mRNA 3′UTR to stabilize it and facilitate nuclear-to-ribosome transport. eEF1A1 depletion severely impairs HSR and thermotolerance. |
siRNA knockdown, ChIP, RNA immunoprecipitation, live-cell imaging, RT-qPCR, thermotolerance assay |
eLife |
High |
25233275
|
| 2014 |
METTL10 trimethylates eEF1A1 at lysine 318 in mammalian cells; siRNA-mediated knockdown of METTL10 decreases eEF1A1 K318 methylation in vivo, as confirmed using a selenium-based SAM analog (ProSeAM) and quantitative MS. |
ProSeAM chemical probe, affinity purification, quantitative MS, siRNA knockdown, biochemical characterization |
PloS one |
High |
25144183
|
| 2015 |
eEF1A is the cytoplasmic retention factor for AID; the mechanism is independent of protein synthesis but requires a tRNA-free form of eEF1A. eEF1A and HSP90 interactions with AID are inversely correlated and define two sequential complexes: HSP90 produces functional AID, which is then stored by eEF1A in the cytoplasm. Inhibiting eEF1A allows AID nuclear accumulation, increasing class switch recombination and chromosomal translocations. |
Chemical inhibition of eEF1A, co-immunoprecipitation, nuclear export assay, class switch recombination assay, chromosomal translocation assay |
The Journal of experimental medicine |
High |
25824822
|
| 2015 |
Direct interaction between eEF1A and HIV-1 reverse transcriptase (RT) has KD ~3–4 nM; both RT thumb and connection domains are required. A single W252A mutation in the RT thumb impairs co-IP with eEF1A and reduces late reverse transcription and virus replication. Didemnin B binds eEF1A and inhibits HIV-1 reverse transcription by >2 logs; W252A RT confers resistance to didemnin B, confirming eEF1A–RT interaction as the antiviral target. |
Biolayer interferometry, co-immunoprecipitation, site-directed mutagenesis, reverse transcription quantification, virus replication assay, drug resistance analysis |
PLoS pathogens |
High |
26624286
|
| 2016 |
FAT10 competes with ubiquitin for binding to the same lysines on eEF1A1, forming FAT10–eEF1A1 complexes instead of Ub–eEF1A1 complexes; FAT10 overexpression therefore decreases eEF1A1 ubiquitination and proteasomal degradation, stabilizing eEF1A1 and promoting cancer cell proliferation. |
Co-immunoprecipitation, ubiquitination assay, lysine mutagenesis, cell proliferation assay |
Cancer research |
Medium |
27312528
|
| 2017 |
METTL21B specifically trimethylates eEF1A Lys-165 in an aminoacyl-tRNA- and GTP-dependent manner; this methylation is dynamic and inducible by ER stress. Genetic ablation of METTL21B in mammalian cells alters mRNA translation dynamics and changes codon-specific translation rates as measured by ribosome profiling. METTL21B also accumulates in centrosomes. |
In vitro methylation assay, in vivo methylation analysis, METTL21B knockout, ribosome profiling, immunofluorescence localization |
Nucleic acids research |
High |
28108655
|
| 2017 |
A novel 7β-strand KMT (eEF1A-KMT4 / EEF1AKMT4) trimethylates eEF1A at Lys36 in vitro and in vivo; KO of this enzyme in mammalian cells alters translation dynamics and changes translation speed of distinct codons by ribosome profiling. |
In vitro methylation assay, KO cell lines, ribosome profiling, active site mutagenesis |
Nucleic acids research |
High |
28520920
|
| 2017 |
Expanded polyalanine tracts function as nuclear export signals by interacting with eEF1A1; GST-pulldown and MS identified eEF1A1 as the binding partner. Knockdown of eEF1A1 partially corrects cytoplasmic mislocalization of expanded poly(A) proteins and restores their nuclear transcription factor function. |
GST pulldown/MS, siRNA knockdown, subcellular localization assay, transcriptional reporter assay |
The Journal of biological chemistry |
Medium |
28246169
|
| 2018 |
Human METTL13 contains two distinct methyltransferase domains: one methylates the eEF1A N-terminus and the other dimethylates Lys55. Structural analysis provided mechanistic detail on N-terminal recognition. Loss of METTL13 function alters translation dynamics and codon-specific translation rates by ribosome profiling. |
In vitro methylation biochemistry, X-ray crystallography (structural analysis), ribosome profiling, domain mutagenesis |
Nature communications |
High |
30143613
|
| 2019 |
METTL13 dimethylates eEF1A Lys55 (eEF1AK55me2) and this modification increases eEF1A's intrinsic GTPase activity in vitro and protein production in cells. METTL13 deletion and loss of eEF1AK55me2 dramatically reduce Ras-driven neoplastic growth in mouse models and patient-derived xenografts. |
In vitro GTPase assay with methylated vs unmethylated eEF1A, METTL13 KO mouse models, PDX models, metabolic labeling of protein synthesis |
Cell |
High |
30612740
|
| 2021 |
Plitidepsin's antiviral activity against SARS-CoV-2 is mediated through inhibition of host eEF1A; a drug-resistant eEF1A mutant demonstrated this mechanistic link, and plitidepsin reduced viral replication by two orders of magnitude in mouse models. |
Drug-resistant mutant selection, in vitro antiviral assay, in vivo mouse infection models |
Science |
High |
33495306
|
| 2022 |
Single-molecule fluorescence imaging and cryo-EM showed that didemnin B and ternatin-4 both bind to a common site on eEF1A·GTP·aa-tRNA ternary complex and trap eEF1A in an intermediate state of aa-tRNA selection, preventing eEF1A release and aa-tRNA accommodation on the ribosome; the two compounds produce distinct effects on ternary complex dynamics that explain differences in their inhibition efficacy. |
Single-molecule FRET imaging, cryogenic electron microscopy, in vitro translation assay |
eLife |
High |
36264623
|
| 2022 |
SR-A3 (a ternatin-family cyclic peptide) binds eEF1A with enhanced residence time and rebinding kinetics compared to SS-A3 epimer; single-molecule fluorescence imaging of elongation reactions with purified eEF1A defined the stereospecific binding kinetics. Prolonged target engagement correlated with antitumor efficacy in a Myc-driven mouse lymphoma model. |
Single-molecule fluorescence imaging (in vitro reconstituted elongation), stereospecific synthesis, in vivo mouse lymphoma model |
Nature chemistry |
High |
36123449
|
| 2006 |
Tetrahymena eEF1A forms homodimers that bundle F-actin; eEF1A dimers (but not monomers) bind and bundle F-actin at a ~1:1 stoichiometry. Ca²⁺/calmodulin converts eEF1A dimers to monomers, releasing them from actin bundles in a reversible manner, providing a Ca²⁺-dependent regulatory mechanism for actin organization. |
Gel filtration chromatography, cosedimentation assay, electron microscopy, Ca²⁺/calmodulin treatment |
Journal of biochemistry |
Medium |
16877446
|
| 2008 |
Domain 3 of Tetrahymena eEF1A is the primary F-actin binding domain and influences dimer formation; all three domains bind calmodulin in a Ca²⁺-dependent manner with distinct Ca²⁺ concentration thresholds, with domain 3 serving a pivotal role in Ca²⁺/calmodulin-regulated actin bundling. |
GST-domain fusion protein binding assays, cosedimentation, calmodulin interaction assay with Ca²⁺ titration |
Zoological science |
Medium |
18275242
|
| 2007 |
ZPR1 binds preferentially to GDP-bound eEF1A; crystal structure of the ZPR1 domain tandem was determined and structure-based mutational analysis identified a conserved eEF1A-binding epitope required for normal cell growth, proliferation, and cell cycle progression. ZPR1 efficiently displaces eEF1Bα from nucleotide-free eEF1A complexes, suggesting it functions as a negative regulator of eEF1A activation. |
X-ray crystallography, co-immunoprecipitation, nucleotide exchange displacement assay, site-directed mutagenesis, yeast complementation |
Proceedings of the National Academy of Sciences of the United States of America |
High |
17704259
|
| 2007 |
PASKIN kinase interacts with eEF1A1 through its PAS A and kinase domains (binding eEF1A1 C-terminus) and phosphorylates eEF1A1 primarily at Thr432; wild-type but not kinase-inactive PASKIN increases in vitro translation of a reporter cRNA, suggesting that PASKIN-dependent phosphorylation of eEF1A1 promotes translation. |
Yeast two-hybrid, mammalian two-hybrid, GST pulldown, in vitro kinase assay, MS, site-directed mutagenesis, in vitro translation assay |
Cellular physiology and biochemistry |
Medium |
17595531
|
| 2010 |
eEF1A1 (but not eEF1A2) interacts with Ca²⁺/calmodulin; this interaction is predicted by molecular dynamics showing a less flexible calmodulin-binding region in eEF1A1, and confirmed experimentally by ELISA-based binding test. Calmodulin binding interferes with tRNA-binding and actin-bundling activities of eEF1A1 in vitro. |
Multiple molecular dynamics simulation, ELISA-based calmodulin binding assay, in vitro tRNA binding, in vitro actin bundling assay |
BMC structural biology |
Medium |
18221514
|
| 2010 |
PKCβI co-immunoprecipitates with eEF1A in the nucleus of insulin-stimulated C2C12 myoblasts and phosphorylates eEF1A2 at Ser53 in vitro; the association between eEF1A2 and PKCβI is dependent on the phosphorylation status of eEF1A2, establishing PKCβI as a nuclear kinase for this elongation factor. |
Nuclear fractionation, co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, LC-MS/MS proteomics |
Molecular & cellular proteomics |
Medium |
20923971
|
| 2002 |
Mammalian eEF1A·GDP forms a stable ternary complex with uncharged tRNA (Kd ~20 nM) and a quaternary complex with phenylalanyl-tRNA synthetase (Kd ~9 nM); direct eEF1A–PheRS interaction (Kd ~21 nM) is accelerated by tRNA, supporting a tRNA-channeling model in which the GDP-bound form of eEF1A participates in tRNA delivery to aminoacyl-tRNA synthetase. |
Gel retardation assay, surface plasmon resonance (BIAcore), fluorescence binding assay |
European journal of biochemistry |
Medium |
12354112
|
| 2024 |
Chp1 is a dedicated ribosome-associated chaperone for eEF1A biogenesis: it is recruited to the ribosome via the nascent polypeptide-associated complex (NAC) during eEF1A synthesis. Absence of Chp1 causes instant proteolysis of nascent eEF1A, widespread protein aggregation, Hsf1 stress activation, and reduced cellular fitness. Chp1 also protects pathogenic eEF1A2 variants linked to epileptic-dyskinetic encephalopathy from degradation. |
Ribosome association assay, proteomics, protein aggregation assay, Hsf1 reporter assay, fitness assay, pathogenic variant expression |
Nature communications |
High |
38360885
|
| 2019 |
Archaeal stalk protein aP1 C-terminal domain (CTD) binds eEF1A·GTP in a space between domains 1 and 3 of eEF1A (crystal structure at 3.0 Å); comparison with the aP1-CTD·eEF1A·GDP structure shows a marked change in binding mode upon GTP/GDP conformational switch, revealing how the stalk supports efficient elongation by engaging eEF1A in both nucleotide states. |
X-ray crystallography (3.0 Å), biochemical binding assay, in vitro translation assay |
Scientific reports |
Medium |
31611569
|
| 2008 |
eEF1A associates with defective ribosomal products via its translation elongation activity and triggers aggresome formation; the novel eEF1A binding protein IGFN1 (found in yeast two-hybrid screen of human skeletal muscle library) interacts with eEF1A in vitro and is upregulated upon muscle denervation, suggesting it downregulates protein synthesis via eEF1A during denervation. |
Yeast two-hybrid, in vitro protein interaction confirmation |
Journal of cellular biochemistry |
Low |
18756455
|
| 2012 |
eEF1A1 interacts with eEF1A1 is a cytoplasmic retention factor for AID; the mechanism requires a tRNA-free form of eEF1A confirmed by the functional consequence that inhibiting eEF1A releases AID to the nucleus increasing class switch recombination. (Note: primary mechanistic finding captured under PMID 22042842 and 25824822 above.) |
Chemical inhibition, nuclear accumulation assay |
The Journal of experimental medicine |
Low |
25824822
|